Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/14/2003US6632928 Immunotoxins and methods of inducing immune tolerance
10/14/2003US6632924 Monitoring activity of glucose transport protein animal with preferential defect; culture mammalian cells, measure concentration of mutant protein in fluid, compare to control, amplified values for test sample indicates translocation
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632919 Bind Watson-Crick base pairs in a double helix; specific for thymidine
10/14/2003US6632800 System for monitoring the expression of transgenes
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632793 Immunological activity for a peptide of the limulus anti-LPS factor
10/14/2003US6632792 Obtainable from Bacillus thuringiensis isolates; combatting chemically resistant strains; endotoxins
10/14/2003US6632791 Thrombomodulin analogs for pharmaceutical use
10/14/2003US6632790 Recombinant DNA produced; pathogen free; high purity
10/14/2003US6632664 Foreign gene inserted into an untranslated region in the genome
10/14/2003US6632663 DNA immunization against chlamydia infection
10/14/2003US6632644 Nucleotide sequences which code for the zwa1 gene
10/14/2003US6632642 Isolated nucleic acid of given sequence; amplification; involved in beer-spoilage
10/14/2003US6632640 Virus replicon vector which contains nucleic acid encoding exotoxin; nucleotide sequence expresses a peptide product that does not bind to major histocomptability complex on T-cells
10/14/2003US6632638 As a fusion partner; useful for suppressing the competing aggregation pathway and facilitating proper folding; escherichia coli
10/14/2003US6632637 Vectors and methods for recombinant protein expression
10/14/2003US6632636 Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalis
10/14/2003US6632635 Methods of refolding proteins
10/14/2003US6632634 Decay accelerating factor (DAF) and nucleic acid encoding it
10/14/2003US6632626 Cancer; anticarcinogenic agents; use of purified enzyme in screening protocols for the identification of possible anti-cancer agents which inhibit the enzyme and thereby prevent expression of the oncogenic ras proteins such as p21ras
10/14/2003US6632625 Ob (obesity gene); receptors may be used in various assays, such as a transactivation assay to identify novel ligands
10/14/2003US6632624 Use immunoassay for precise measurement of levels of intact chromogranin A and the levels of major fragments found in circulating blood
10/14/2003US6632621 Drug screening; neuropeptides; ligands; mimetics; anthelmin-tics; use for screening and identification of materials that inhibit/interfer with the neurological activity of targeted invertebrates while minimizing effects on non-pest species
10/14/2003US6632618 Morphogenic protein-specific cell surface receptors and uses therefor
10/14/2003US6632617 Tumor-associated antigen
10/14/2003US6632613 Compositions and kits for fluorescence polarization assay of large molecules
10/14/2003US6632608 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/14/2003US6632604 Nucleic acid sequences of CIITA genes which can be involved in controlling and regulating the expression of genes encoding MHC type II molecules, and their use, in particular as drugs
10/14/2003US6632602 Transgenic plants; use to alter levels of hexokinase protein expression in plants in order to repress/activate plant genes controlling physiology, metabolism, and cell development with emphasis on improved yields and quality of agricultural crops
10/14/2003US6632601 Immunoassays for anti-HCV antibodies
10/14/2003US6632441 Mutants of streptococcal toxin a and methods of use
10/14/2003US6632440 Chronic obstructive pulmonary disease (COPD), asthma; Aerosol administration a compound that inhibits exocytosis in mucus secreting cells produced by modifying a clostridial neurotoxin
10/14/2003US6632434 Leptospiral major outer membrane protein, LipL 32
10/14/2003US6632433 Treating cholinergic controlled secretions including excess sweating, lacrimation and mucus secretion to reduce them; smooth muscle disorders; antispasmodic agents; analgesics; cardiovascular arterioles; gastrointestinal disorders
10/14/2003US6632431 Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same
10/14/2003US6632426 G-CSF analog compositions and methods
10/14/2003US6632425 Chemokine compositions
10/14/2003US6632424 Stimulate proliferation of hematopoietic stem or progenitor cells
10/14/2003CA2290776C Proteins having insecticidal activities and method of use
10/14/2003CA2288376C Syndecan interacting proteins and the use thereof
10/14/2003CA2263790C Method for immortalizing cells
10/14/2003CA2223505C Anti-fungal and anti-bacterial histatin-based peptides
10/14/2003CA2165828C Peptidase resistant thrombin receptor peptide ligand
10/14/2003CA2150225C A process for the purification of natural pulmonary surfactant material using supercritical fluids
10/14/2003CA2107894C Crosstalk inhibitors and their uses
10/14/2003CA2080018C Novel t-cell lymphoma cdna clones
10/12/2003CA2425021A1 Control of the ratio of lap to lip
10/09/2003WO2003083472A1 Method of judging risk of peiodontal disease
10/09/2003WO2003083436A2 Fibrinogen binding moieties
10/09/2003WO2003083139A1 Method of examining allergic disease
10/09/2003WO2003083125A1 Ehanced protein expression in bacillus
10/09/2003WO2003083124A2 Peptide epitopes common to antigens of the same multigene family
10/09/2003WO2003083121A1 A calcium ion channel
10/09/2003WO2003083117A2 Vascularization controlling gene
10/09/2003WO2003083116A1 Emthod of screening transporter inhibitor
10/09/2003WO2003083115A1 Abc transporter-associated gene abcc13
10/09/2003WO2003083114A1 Antiopoietin-related growth factor
10/09/2003WO2003083113A2 Growth regulating proteins
10/09/2003WO2003083104A1 Method for making purified plasminogen activator-inhibitor type 1 (pai-1) and purified pai-1 made thereform
10/09/2003WO2003083103A1 Materials and methods for inhibiting wip-1
10/09/2003WO2003083102A2 Cancer associated protein phosphatases and their uses
10/09/2003WO2003083101A1 Dap kinase crystals, method of screening candidate for drug targeting dap kinase using the same and drug obtained thereby
10/09/2003WO2003083099A2 Purified polypeptides involved in protein synthesis and modification
10/09/2003WO2003083095A1 Viral mutants, manipulated in the furin cleavage sites of glycoproteins
10/09/2003WO2003083094A1 Hbv drug resistance drug resistance detection methods
10/09/2003WO2003083093A1 Host cells having improved cell survival properties and methods to generate such cells
10/09/2003WO2003083085A2 Transporters and ion channels
10/09/2003WO2003083084A2 Protein modification and maintenance molecules
10/09/2003WO2003083083A2 Methods of using flt3-ligand in immunization protocols
10/09/2003WO2003083081A2 Lipid-associated molecules
10/09/2003WO2003083079A2 Bone generation by gene therapy
10/09/2003WO2003083078A2 Novel human cell surface protein with immunoglobulin folds, bgs-19
10/09/2003WO2003083076A2 Polynucleotides encoding novel two splice variants of a human cell surface protein with immunologobulin folds, bgs5g and bgs5i
10/09/2003WO2003083073A2 Binding assay employing gpcr 192
10/09/2003WO2003083059A2 Mcp-1 mutant proteins, antibodies, compositions, methods and uses
10/09/2003WO2003083058A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003WO2003083049A2 Cloning and characterization of g+c-rich promoter binding protein
10/09/2003WO2003083048A2 Novel secreted proteins and their uses
10/09/2003WO2003083041A2 Cripto-specific antibodies
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082988A1 Nir-fluorescent cyanine dyes, their synthesis and biological use
10/09/2003WO2003082924A1 Immunotherapeutic and immunoprophylactic reagents
10/09/2003WO2003082921A1 Lactoferrin
10/09/2003WO2003082920A1 Chemokines and uses thereof
10/09/2003WO2003082919A2 Ox40r binding agents
10/09/2003WO2003082918A1 Vegf peptides and their use
10/09/2003WO2003082917A1 Novel polypeptide and nucleic acid encoding the same
10/09/2003WO2003082916A2 Tumour associated antigens
10/09/2003WO2003082915A2 Xcrf polynucleotides and polypeptides and uses thereof
10/09/2003WO2003082914A1 Prothrombin activating protein
10/09/2003WO2003082913A1 Genes from drought stress tolerant tea plant and a method of introducing water-stress tolerance
10/09/2003WO2003082912A2 Transgenic plants expressing mussel adhesive proteins
10/09/2003WO2003082911A2 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics
10/09/2003WO2003082910A1 Chimeric delta endotoxin protein of cry1ea and cry1ca
10/09/2003WO2003082908A2 Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein
10/09/2003WO2003082907A1 Ligands for g protein coupled receptor gpr7 and uses thereof
10/09/2003WO2003082906A2 Neurotrophic and neuroprotective peptides
1 ... 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 ... 2916